IFS has clearly failed to deliver on its promise. It has been one of my losers for this year. Still holding some options.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025